13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 68 holding rows worth $2,322,922,487.
- Accession
- 0001172661-26-003529
- Filer
- CIK 1792126
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 68 entries on the cover page, a total value of $2,322,922,487 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,322,922,487 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ERASCA INC COM | 29479A108 | Stock | 12,150,000 | $222,588,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,024,000 | $136,458,240 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 700,000 | $131,096,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,000,000 | $111,810,000 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 1,015,000 | $94,445,750 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,200,000 | $94,402,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,850,000 | $89,091,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 260,000 | $87,045,400 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,100,000 | $78,141,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 800,000 | $77,984,000 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,000,000 | $71,050,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 875,000 | $63,997,500 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,935,000 | $57,740,400 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,550,000 | $56,635,500 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 2,675,000 | $52,082,250 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,300,000 | $52,046,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 3,000,000 | $43,410,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $40,143,026 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 250,000 | $38,496,250 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 5,425,000 | $35,425,250 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,880,000 | $35,062,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 900,000 | $34,830,000 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,000,000 | $34,740,000 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,900,000 | $34,200,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 2,250,000 | $31,837,500 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 1,050,000 | $28,329,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 2,500,000 | $27,675,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 450,000 | $27,162,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 500,000 | $26,835,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 665,000 | $25,622,450 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,125,000 | $24,997,500 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 465,000 | $23,598,750 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 180,000 | $22,129,200 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,150,000 | $21,252,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 650,000 | $20,039,500 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 1,350,000 | $19,669,500 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 600,000 | $19,050,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 585,000 | $18,986,175 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 3,288,777 | $18,252,712 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 722,020 | $18,050,500 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 300,000 | $16,362,000 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 915,000 | $15,006,000 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 525,000 | $14,369,250 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 125,000 | $13,878,750 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 650,000 | $11,966,500 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 200,000 | $11,000,000 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 1,000,000 | $10,310,000 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 800,000 | $10,192,000 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 521,736 | $9,761,681 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 1,500,000 | $8,565,000 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 2,222,000 | $7,199,280 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 350,000 | $6,548,500 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 250,000 | $6,325,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 350,000 | $6,286,000 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 750,000 | $4,957,500 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 963,855 | $4,395,179 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 300,000 | $4,365,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 80,000 | $3,763,200 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 473,563 | $2,221,010 | dollars as filed | |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 130,000 | $1,402,700 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 30,000 | $1,381,800 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 100,000 | $1,136,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 100,000 | $1,070,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 200,000 | $1,058,000 | dollars as filed | |
| LONGEVERON INC | 54303L203 | CL A NEW | 1,287,000 | $904,761 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,000,000 | $794,400 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 23,548 | $788,623 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 50,000 | $508,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-003529 | this filing | 2026-08-14 | acceptance time not in the bulk data set |